Welcome to GTx, a biopharmaceutical company dedicated to the discovery, development, and
commercialization of small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions.
Our recognized scientific expertise is in the discovery and development of novel, selective small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions. Click to learn more about our products in development.
GTx is a biopharmaceutical company dedicated to the discovery, development and commercialization of drug candidates. Click to learn more about the GTx management team.
GTx Provides Corporate Update and Reports First Quarter 2013 Financial Results 
GTx Initiating Phase 2, Open-Label Study of Enobosarm to Treat ER Positive Metastatic Breast Cancer
GTx, Inc. To Host First Quarter 2013 Financial Results Conference Call and Webcast